Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2019

01-02-2019 | Original Article

Gender Impacts on the Disease Severity of Overt Acute Hepatitis A: Different from Overt Acute Hepatitis B

Authors: Ming-Ling Chang, Yun-Fan Liaw

Published in: Digestive Diseases and Sciences | Issue 2/2019

Login to get access

Abstract

Background

Acute hepatitis A (AH-A) and acute hepatitis B (AH-B) were found more severe in males and females, respectively, while impacts from underlying liver disease on severity were not excluded in the AH-A study.

Aim

The precise gender-specific impact on the severity of AH-A was investigated and compared with that of AH-B.

Methods

A case–control study of overt AH-A (n = 118) and AH-B (n = 118) patients without any underlying liver disease was conducted. Overt hepatitis was defined as serum bilirubin ≥ 2 mg/dL and alanine transaminase (ALT) ≥ 10 × upper limit of normal.

Results

Of the AH-A patients, age (95% confidence interval of odds ratio 1.051–1.147) and ALT (1.001–1.002) were associated with hepatic decompensation. Indifferent rates of hepatic decompensation, hepatic failure, and mortality were found between male and female patients. Compared with the AH-B patients, AH-A patients showed lower bilirubin levels (p < 0.001), hepatic decompensation (p = 0.004), and mortality rates (p = 0.013). Among patients < 40 years, the AH-A patients had higher hepatic decompensation rates than AH-B in the male subgroup (15% vs. 2.8%, p = 0.045), while the situation is reverse in the female subgroup (7.7% vs. 48.1%, p = 0.001).

Conclusions

Overt AH-A was less severe than overt AH-B and, unlike AH-B, had no difference in severity between males and females. Among subgroups < 40 years, AH-A was more severe than AH-B in males, but the situation was reverse in females in terms of hepatic decompensation rates.
Appendix
Available only for authorised users
Literature
3.
go back to reference Yoo SH, Kim IH, Jang JW, et al. Clinical features and risk factors for severe complications among patients with acute hepatitis A virus infection in the Jeonbuk Province of Korea. Korean J Gastroenterol. 2014;63:25–31.CrossRefPubMed Yoo SH, Kim IH, Jang JW, et al. Clinical features and risk factors for severe complications among patients with acute hepatitis A virus infection in the Jeonbuk Province of Korea. Korean J Gastroenterol. 2014;63:25–31.CrossRefPubMed
5.
go back to reference Becker U, Deis A, Sørensen TI, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology. 1996;23:1025–1029.CrossRefPubMed Becker U, Deis A, Sørensen TI, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology. 1996;23:1025–1029.CrossRefPubMed
6.
go back to reference Reuben A, Koch DG, Lee WM, et al. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology. 2010;52:2065–2076.CrossRefPubMed Reuben A, Koch DG, Lee WM, et al. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology. 2010;52:2065–2076.CrossRefPubMed
8.
9.
go back to reference Chang ML, Liaw YF. Overt acute hepatitis B is more severe in female patients. Hepatology. 2017;66:995–996.CrossRefPubMed Chang ML, Liaw YF. Overt acute hepatitis B is more severe in female patients. Hepatology. 2017;66:995–996.CrossRefPubMed
10.
go back to reference Chen CM, Chen SC, Yang HY, et al. Hospitalization and mortality due to hepatitis A in Taiwan: a 15-year nationwide cohort study. J Viral Hepat. 2016;23:940–945.CrossRefPubMed Chen CM, Chen SC, Yang HY, et al. Hospitalization and mortality due to hepatitis A in Taiwan: a 15-year nationwide cohort study. J Viral Hepat. 2016;23:940–945.CrossRefPubMed
11.
go back to reference Chang ML, Jeng WJ, Liaw YF. Clinical events after cessation of lamivudine therapy in patients recovered from hepatitis B flare with hepatic decompensation. Clin Gastroenterol Hepatol. 2015;13:979–986.CrossRefPubMed Chang ML, Jeng WJ, Liaw YF. Clinical events after cessation of lamivudine therapy in patients recovered from hepatitis B flare with hepatic decompensation. Clin Gastroenterol Hepatol. 2015;13:979–986.CrossRefPubMed
12.
go back to reference Tsai SH, Chang HM, Hsieh CB, et al. Acute fulminant hepatitis B in a patient with diabetic nephropathy treated successfully with concomitant lamivudine and molecular adsorbents recirculating system. J Infect. 2006;53:e19–e23.CrossRefPubMed Tsai SH, Chang HM, Hsieh CB, et al. Acute fulminant hepatitis B in a patient with diabetic nephropathy treated successfully with concomitant lamivudine and molecular adsorbents recirculating system. J Infect. 2006;53:e19–e23.CrossRefPubMed
13.
go back to reference Sampliner RE, Woronow DI, Alter MJ, et al. Community-acquired non-A, non-B hepatitis: clinical characteristics and chronicity. J Med Virol. 1984;13:125–130.CrossRefPubMed Sampliner RE, Woronow DI, Alter MJ, et al. Community-acquired non-A, non-B hepatitis: clinical characteristics and chronicity. J Med Virol. 1984;13:125–130.CrossRefPubMed
14.
go back to reference Chu CM, Sheen IS, Liaw YF. The etiology of acute hepatitis in Taiwan: acute hepatitis superimposed upon HBsAg carrier state as the main etiology of acute hepatitis in areas with high HBsAg carrier rate. Infection. 1988;16:233–237.CrossRefPubMed Chu CM, Sheen IS, Liaw YF. The etiology of acute hepatitis in Taiwan: acute hepatitis superimposed upon HBsAg carrier state as the main etiology of acute hepatitis in areas with high HBsAg carrier rate. Infection. 1988;16:233–237.CrossRefPubMed
15.
go back to reference Chu CM, Liaw YF. The incidence of fulminant hepatic failure in acute viral hepatitis in Taiwan: increased risk in patients with pre-existing HBsAg carrier state. Infection. 1990;18:200–203.CrossRefPubMed Chu CM, Liaw YF. The incidence of fulminant hepatic failure in acute viral hepatitis in Taiwan: increased risk in patients with pre-existing HBsAg carrier state. Infection. 1990;18:200–203.CrossRefPubMed
16.
go back to reference Reiss G, Keeffe EB. Review article: hepatitis vaccination in patients with chronic liver disease. Aliment Pharmacol Ther. 2004;19:715–727.CrossRefPubMed Reiss G, Keeffe EB. Review article: hepatitis vaccination in patients with chronic liver disease. Aliment Pharmacol Ther. 2004;19:715–727.CrossRefPubMed
17.
go back to reference Rakela J, Redeker AG, Edwards VM, et al. Hepatitis A virus infection in fulminant hepatitis and chronic active hepatitis. Gastroenterology. 1978;74:879–882.CrossRefPubMed Rakela J, Redeker AG, Edwards VM, et al. Hepatitis A virus infection in fulminant hepatitis and chronic active hepatitis. Gastroenterology. 1978;74:879–882.CrossRefPubMed
19.
go back to reference Gimson AE, White YS, Eddleston AL, et al. Clinical and prognostic differences in fulminant hepatitis type A, B and non-A non-B. Gut. 1983;24:1194–1198.CrossRefPubMedPubMedCentral Gimson AE, White YS, Eddleston AL, et al. Clinical and prognostic differences in fulminant hepatitis type A, B and non-A non-B. Gut. 1983;24:1194–1198.CrossRefPubMedPubMedCentral
20.
go back to reference Okuno T, Sano A, Deguchi T, et al. Pathology of acute hepatitis A in humans. Comparison with acute hepatitis B. Am J Clin Pathol. 1984;81:162–169.CrossRefPubMed Okuno T, Sano A, Deguchi T, et al. Pathology of acute hepatitis A in humans. Comparison with acute hepatitis B. Am J Clin Pathol. 1984;81:162–169.CrossRefPubMed
21.
go back to reference Tsui JI, Mirzazadeh A, Hahn JA, et al. The effects of alcohol on spontaneous clearance of acute hepatitis C virus infection in females versus males. Drug Alcohol Depend. 2016;169:156–162.CrossRefPubMedPubMedCentral Tsui JI, Mirzazadeh A, Hahn JA, et al. The effects of alcohol on spontaneous clearance of acute hepatitis C virus infection in females versus males. Drug Alcohol Depend. 2016;169:156–162.CrossRefPubMedPubMedCentral
22.
go back to reference van Lunzen J, Altfeld M. Sex differences in infectious diseases-common but neglected. J Infect Dis. 2014;209:S79–S80.CrossRefPubMed van Lunzen J, Altfeld M. Sex differences in infectious diseases-common but neglected. J Infect Dis. 2014;209:S79–S80.CrossRefPubMed
23.
go back to reference Grebely J, Page K, Sacks-Davis R, et al. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2014;59:109–120.CrossRefPubMed Grebely J, Page K, Sacks-Davis R, et al. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2014;59:109–120.CrossRefPubMed
24.
go back to reference Burguete-Garcia AI, Conde-Gonzalez CJ, Jimenez-Mendez R, et al. Hepatitis C seroprevalence and correlation between viral load and viral genotype among primary care clients in Mexico. Salud Publica Mex. 2011;53:S7–S12.PubMed Burguete-Garcia AI, Conde-Gonzalez CJ, Jimenez-Mendez R, et al. Hepatitis C seroprevalence and correlation between viral load and viral genotype among primary care clients in Mexico. Salud Publica Mex. 2011;53:S7–S12.PubMed
Metadata
Title
Gender Impacts on the Disease Severity of Overt Acute Hepatitis A: Different from Overt Acute Hepatitis B
Authors
Ming-Ling Chang
Yun-Fan Liaw
Publication date
01-02-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5340-9

Other articles of this Issue 2/2019

Digestive Diseases and Sciences 2/2019 Go to the issue